International Clinical Trial: Efficacy of Romiplostim and Avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in breast cancer: a multicenter, randomized controlled clinical trial

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119903) titled 'Efficacy of Romiplostim and Avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in breast cancer: a multicenter, randomized controlled clinical trial' on March 5.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Chemotherapy-induced thrombocytopenia

Intervention: Experimental group:Romiplostim administered by subcutaneous injection

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: Experimental group:90;C...